15.07.2014 Views

Form 20-F 2005

Form 20-F 2005

Form 20-F 2005

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Operating expenses<br />

The following table shows financial data relating to our operating expenses for <strong>20</strong>04 and <strong>20</strong>05:<br />

For the years ended<br />

(in millions of euros) <strong>20</strong>05 <strong>20</strong>04 % change<br />

Cost of sales (4,6<strong>20</strong>) (4,408) 4.8%<br />

Administrative and selling expenses (574) (513) 12%<br />

Research and development expenditure (124) (138) (10)%<br />

Restructuring costs (87) (169) (49)%<br />

Goodwill impairment (60)<br />

Other operating income/(expenses) (43) (46) (6.5)%<br />

Total (5,448) (5,334) 2%<br />

Cost of sales<br />

Cost of sales increased by €212 million from €4,408 million in <strong>20</strong>04 to €4,6<strong>20</strong> million in <strong>20</strong>05. This significant 5% cost increase<br />

reflects oil derivatives, particularly benzene, benzene derivatives and natural gas price trends.<br />

Administrative and selling expenses<br />

Administrative and selling expenses rose by €61 million compared with <strong>20</strong>04 mainly due to the following factors:<br />

the appreciation of the Brazilian real by <strong>20</strong>% against the euro had an impact of €9 million.<br />

the costs of implementing the global project to improve central information systems for €<strong>20</strong> million.<br />

This project is a key factor in improving our performance and efficiency.<br />

the payment by our captive insurance firm of €13 million in compensation for the flooding of the Swiss Emmenbrücke plant.<br />

Sarbanes-Oxley project costs totaled €3 million.<br />

Research and development expenditure<br />

Research and development expenditure fell 10% due to measures to optimize R&D organization and efficiency.<br />

Restructuring costs<br />

Restructuring and reorganization measures continued in <strong>20</strong>05, totaling €87 million, and mainly involved industrial streamlining<br />

programs and operating performance improvement plans. This should be compared with the €169 million cost incurred in <strong>20</strong>04,<br />

the first year of our recovery plan initiated in October <strong>20</strong>03.<br />

The new measures in <strong>20</strong>05 essentially correspond to the following:<br />

In France:<br />

closure of a textile production site in Arras at Polyamide;<br />

“horizon” project in order to reorganize our industrial platform in Pont-de-Claix (Isère) at Coatis;<br />

productivity measures on the Saint-Fons site (Rhône) at Silcea.<br />

<strong>Form</strong> <strong>20</strong> - F <strong>20</strong>05 - Rhodia<br />

45

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!